Enhancing Personalised Care in HR+ Early Breast Cancer: How MGAs Help to Individualise Risk-based Systematic Treatment Decisions
Loading component...
Agenda
12:15 – 12:20
Welcome and Introduction
Giampaolo Bianchini
12:20 – 12:35
Prognosis vs Prediction: Does high-risk mean high response?
Shani Paluch-Shimon
12:35 – 15:50
Incorporating genomic testing when considering adjuvant CDK4/6 inhibitor
Giampaolo Bianchini
12:50 – 13:05
Where are we with personalised approaches for node-positive patients?
Mattea Reinisch
13:05 – 13:15
Panel discussion / Q&A
Giampaolo Bianchini, Shani Paluch-Shimon, Mattea Reinisch


